Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of gastroenterology

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s005350050358PMID 10832668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intestinal Distribution and Intraluminal Localization of Orally Administered Clostridium butyricum in Rats

  1997cited by this paper
• Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas.

  1996cited by this paper
• Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.

  1996cited by this paper
• Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model.

  1996cited by this paper
• Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate

  1995cited by this paper
• Role of short-chain fatty acids in the prevention of colorectal cancer.

  1995cited by this paper
• Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.

  1995cited by this paper
• Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate

  1995cited by this paper
• Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.

  1994cited by this paper
• Butyrate production from dietary fibre and protection against large bowel cancer in a rat model.

  1993cited by this paper
• [Study on the experimental ulcerative colitis model induced by dextran sulfate sodium in rats: estimation of mucosal erosions by the alcian blue-staining method].

  1993cited by this paper
• Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.

  1992cited by this paper
• Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids.

  1989cited by this paper
• Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors

  1987cited by this paper
• KM1, a Bacteriophage of Clostridium butyricum

  1986cited by this paper
• [Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora].

  1985cited by this paper
• Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models

  1984cited by this paper
• Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

  1984cited by this paper
• The colonic epithelium in ulcerative colitis: an energy-deficiency disease?

  1980cited by this paper

• Perioperative administration of CBM588 in colorectal cancer radical surgery: A single-center, randomized controlled trial

  2025cites this paper
• Effects of Clostridium butyricum on Physiological Parameters and Gut Microbiota in Newborn Hanwoo Calves

  2025cites this paper
• Modulatory Effects of Bifidobacterium longum Subsp. Longum BL21 on Intestinal Barrier Impairment and Metabolic Dysregulation in a Low‐Dose Dextran Sulfate Sodium‐Induced Chronic Inflammation Model

  2025cites this paper
• Harnessing Probiotics to Combat Candidiasis: Mechanisms, Evidence, and Future Directions

  2025cites this paper
• Construction of a metabolic‐immune model for predicting the risk of diabetic nephropathy and study of gut microbiota

  2025cites this paper
• Characterisation of potential anti-inflammatory next-generation probiotics resistant to bisphenol A.

  2024cites this paper
• The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-Radiotherapy

  2024cites this paper
• Preliminary study on the potential impact of probiotic combination therapy on Helicobacter pylori infection in children using 16S gene sequencing and untargeted metabolomics approach

  2024cites this paper
• Mechanisms of microbial interactions between probiotic microorganisms and Helicobacter pylori

  2023cites this paper
• Inhibitory effects of Clostridium butyricum culture and supernatant on inflammatory colorectal cancer in mice

  2023cites this paper
• Clostridium butyricum Strain MIYAIRI 588 (CBM588) as a Precision Probiotic Therapy in the Ketogenic Diet: A Possible Application?

  2023cites this paper
• Pathobionts from chemically disrupted gut microbiota induce insulin-dependent diabetes in mice

  2023cites this paper
• Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review

  2023cites this paper
• Non‐Lactic Acid Bacteria as Probiotics and their Functional Roles

  2022cites this paper
• Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

  2022cites this paper
• Proof-of-Principle Study Suggesting Potential Anti-Inflammatory Activity of Butyrate and Propionate in Periodontal Cells

  2022cites this paper
• Probiotics in the treatment of Helicobacter pylori infection: reality and perspective.

  2022cites this paper
• Pathobionts from chemically disrupted gut microbiota induce insulin-dependent diabetes in mice

  2022cites this paper
• Change in gut histomorphology and microbiota in Chinese strip‐necked turtle hatchlings

  2021cites this paper
• Prospects for clinical applications of butyrate-producing bacteria

  2021cites this paper
• Clostridium butyricum Supernatant Regulates the Expression of RORγt in HCT-116 Cells by Inhibiting the TLR2/MyD88/NF-κB Signaling Pathway

  2021cites this paper
• The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine–Dependent but GPR43/109a-Independent Mechanisms

  2021cites this paper
• Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease.

  2020cites this paper
• Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice.

  2020cites this paper
• Clostridium butyricum protects intestinal barrier function via upregulation of tight junction proteins and activation of the Akt/mTOR signaling pathway in a mouse model of dextran sodium sulfate-induced colitis

  2020cites this paper
• Effect of Clostridium butyricum and Butyrate on Intestinal Barrier Functions: Study of a Rat Model of Severe Acute Pancreatitis With Intra-Abdominal Hypertension

  2020cites this paper
• Protective Effects of Clostridium Butyricum in a Murine Model of Dextran Sodium Sulfate-Induced Colitis That Involve Inhibition of the TLR2 Signaling Pathway and T Helper 17 Cells.

  2020cites this paper
• Gut microbiota in health and disease

  2019cites this paper
• Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives

  2019cites this paper
• In vivo safety evaluation of the Clostridium butyricum MIYAIRI 588 strain in broilers, piglets, and turkeys

  2019cites this paper
• Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients.

  2019cites this paper
• Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis

  2018cites this paper
• Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial

  2018cites this paper
• The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial

  2018cites this paper
• Trial in using Clostridium butyricum as Prophylactic for Salmonellosis in Broiler Chicken : Hemato-biochemical , Immunological and Pathological Alterations

  2018cites this paper
• Effect of Clostridium butyricum and its components in different concentrations on epithelial-mesenchymal transition of ulcerative colitis

  2018cites this paper
• Effects of the butyric acid-producing strain Clostridium butyricum MIYAIRI 588 on broiler and piglet zootechnical performance and prevention of necrotic enteritis.

  2018cites this paper
• Inhibitory Effect of Clostridium butyricum on Intestinal Damage of Lipopolysaccharide-Induced Acute Stress Rats

  2018cites this paper
• Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses

  2017cites this paper
• Intermittent fasting prompted recovery from dextran sulfate sodium-induced colitis in mice

  2017cites this paper
• Protection Mechanism of Clostridium butyricum against Salmonella Enteritidis Infection in Broilers

  2017cites this paper
• The role of enzymes and binding modules in the degradation of eukaryotic, microbial and plant cell walls

  2016cites this paper
• Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium

  2016cites this paper
• Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice

  2016cites this paper
• A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease

  2015cites this paper
• Effects of Clostridium butyricum on growth performance, antioxidation, and immune function of broilers.

  2015cites this paper
• Effects of Clostridium butyricum on antioxidant properties, meat quality and fatty acid composition of broiler birds

  2015cites this paper
• Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model.

  2015cites this paper
• Induction of Peroxisomes by Butyrate-Producing Probiotics

  2015cites this paper
• Genome sequencing of Clostridium butyricum DKU-01, isolated from infant feces

  2015cites this paper
• Physiology and Sporulation in Clostridium

  2014cites this paper
• An analysis of microbiota-targeted therapies in

  2014cites this paper
• Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.

  2014cites this paper
• Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing.

  2014cites this paper
• The microbiome and regulation of mucosal immunity

  2014cites this paper
• An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection

  2014cites this paper
• Microbiota-derived lactate accelerates colon epithelial cell turnover in starvation-refed mice

  2013cites this paper
• Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8.

  2013cites this paper
• Diet, Microbiome, and the Intestinal Epithelium: An Essential Triumvirate?

  2013cites this paper
• The (13)C-butyrate breath test: a new non-invasive method for assessing colitis in a murine model.

  2013cites this paper
• Clostridium Butyricum MIYAIRI 588 Improves High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats

  2013cites this paper
• Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis

  2013cites this paper
• Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides

  2012cites this paper
• Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate‐induced colitis: differential regulation of tumour necrosis factor‐α and interleukin‐18 in BALB/c and severe combined immunodeficiency mice

  2012cites this paper
• Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS‐induced colitis

  2011cites this paper
• Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain.

  2011cites this paper
• Impact of Fiber on Gastrointestinal Microbiota

  2011cites this paper
• From the gut to the peripheral tissues: the multiple effects of butyrate

  2010cites this paper
• Effects of fructo-oligosaccharide on DSS-induced colitis differ in mice fed nonpurified and purified diets.

  2010cites this paper
• Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.

  2010cites this paper
• Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

  2010cites this paper
• Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate†

  2010cites this paper
• Probiotics and Iletis

  2010cites this paper
• Control of mucosal polymicrobial populations by innate immunity

  2009cites this paper
• Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes.

  2008cites this paper
• Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

  2008cites this paper
• Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota

  2008cites this paper
• Clostridium butyricum TO-A Culture Supernatant Downregulates TLR4 in Human Colonic Epithelial Cells

  2007cites this paper
• Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.

  2007cites this paper
• 4.34 – Immunomodulating Activity of Plant Polysaccharide Structures

  2007cites this paper
• Short-chain fatty acid mediated phosphorylation of heat shock protein 25: effects on camptothecin-induced apoptosis.

  2006cites this paper
• The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice.

  2005cites this paper
• Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice.

  2005cites this paper
• Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy.

  2005cites this paper
• Nutrition and Cancer Oral Administration of Butyrivibrio fibrisolvens , a Butyrate-Producing Bacterium , Decreases the Formation of Aberrant Crypt Foci in the Colon and Rectum of Mice 1 , 2

  2005cites this paper
• Tolerogenic Dendritic Cells: Immunomodulation of Monocyte-Derived Dendritic Cells with n-Butyrate, NFκB Inhibitor PDTC and JAK3 Inhibitor WHI-P-154

  2005cites this paper
• Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice.

  2005cites this paper
• The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.

  2004cites this paper
• Use of Probiotics in inflammatory bowel disease

  2003cites this paper
• Probiotics and the Colon

  2003cites this paper
• Short-chain fatty acids: bacterial mediators of a balanced host-microbial relationship in the human gut.

  2002cites this paper
• Bacterial metabolite interference with maturation of human monocyte‐derived dendritic cells

  2002cites this paper
• Prebiotics and human health: The state-of-the-art and future perspectives

  2001cites this paper
• Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse.

  2001cites this paper